Showing 13,041 - 13,060 results of 46,970 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 1.16s Refine Results
  1. 13041

    Activation of deep SC neurons recapitulates delayed LER in <i>Setd5</i><sup><i>+/−</i></sup> animals. by Laura E. Burnett (18794525)

    Published 2024
    “…(<b>I</b>) Proportion of trials at different laser intensities that either show an increase (white), decrease (black), or no change (grey) in speed upon light activation for <i>Setd5</i><sup>+/+</sup> (top) and <i>Setd5</i><sup>+/<i>−</i></sup> (bottom). 0.01 mW mm<sup>−2</sup>: 35 trials, <i>p</i> = 0.649; 0.5 mW mm<sup>−2</sup>: 111 trials, <i>p</i> = 0.193; 5 mW mm<sup>−2</sup>: 50 trials, <i>p</i> < 0.001; 10 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001; 15 mW mm<sup>−2</sup>: 61 trials, <i>p</i> = 0.004; 20 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001, X<sup>2</sup> test of independence. …”
  2. 13042
  3. 13043
  4. 13044
  5. 13045

    Directed evolution of HIV-1 to utilize CD4<sup>low</sup> target cells. by David Beauparlant (3491435)

    Published 2017
    “…<b>(E)</b> Adaptation to CD4<sup>low</sup> target cells results in high resistance to CD4 inhibitor compared to wild type HIV-1 isolates. Comparison of IC50 of CD4-blocking DARPin 55.2 against 41 wild-type HIV-1 strains from different clades (black dots, see <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006255#ppat.1006255.s003" target="_blank">S3 Table</a> for details on virus panel and individual IC50 values) and the CD4<sup>low</sup> adaptation virus panel (colored dots, see legend) probed by Env pseudovirus infection on TZM-bl cells. …”
  6. 13046
  7. 13047
  8. 13048
  9. 13049
  10. 13050
  11. 13051

    Dysregulated alternative splicing in DM1 hiNeurons at 10 DPI. by Mougina K. Eltahir (12988153)

    Published 2022
    “…(d) Scatter plots pertaining to Fig 5c show decreased inclusion of <i>MAPT</i> e2 (top), <i>CSNK1D</i> e9 (bottom left) and <i>MPRIP</i> e9 (bottom right) in DM1 hiNeurons. …”
  12. 13052
  13. 13053

    Efficacy of R-LM113 and R-115 administered early after tumor implantation on the growth of HER2-LLC1 tumors. by Valerio Leoni (440542)

    Published 2018
    “…The mice decreased in number because of deaths caused by the primary tumor. …”
  14. 13054
  15. 13055
  16. 13056
  17. 13057
  18. 13058
  19. 13059

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”
  20. 13060

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”